Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice

Journal of Lipid Research

Volumn 42, Issue 6, 2001, Pages 943-950

  Kawashiri, M A ^a   Zhang, Y ^a   Usher, D ^a   Reilly, M ^a   Pure E ^a   Rader, D J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gene transfer; Lipoprotein metabolism; Low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN E3; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; GENE TRANSFER; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LAC OPERON; LIPIDS; LIPOPROTEINS; MACROPHAGES; MALE; MICE; MYOCARDIUM; RECEPTORS, LDL; TIME FACTORS;

EID: 0034967150     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. A receptor-mediated pathway for cholesterol homeostasis
2. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
3. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
4. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
5. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
6. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remants
7. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
8. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
9. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer
10. Apolipoprotein E deficiency in mice: Gene replacement and prevention of atherosclerosis using adenovirus vectors
11. Liver-directed gene transfer and prolonged expression of three major human apoE isoforms in apoE-deficient mice
12. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
13. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation
14. Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance
15. Overexpression of apolipoprotein E in transgenic mice: Marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia
16. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B
17. Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice
18. Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E
19. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma
20. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse
21. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
22. Rapid regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein E in apoE deficient mice
23. Complete atherosclerosis regression after human apoE gene transfer in apoE-deficient/nude mice
24. Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
25. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice
26. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E
27. Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice
28. In vivo correction of low density lipoprotein receptor deficiency in the watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses
29. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
30. Apolipoprotein E metabolism in normolipoproteinemic human subjects
31. In vivo metabolism of apolipoprotein E in humans
32. Hepatic apoE expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor
33. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE
34. Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond
35. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice
36. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes
37. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia
38. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice
39. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing VLDL receptor
40. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages